Paras Healthcare: Acquirers Disclose Shareholding under SEBI SAST Regs

Paras Healthcare Ltd has received disclosures from several entities, including 360 ONE Special Opportunities Fund - Series 9 to 13 and 360 ONE Private Equity Fund - Series 2, and 360 ONE Equity Opportunity Fund - Series 4, acting as acquirers. These disclosures, made under Regulation 29(1) of the SEBI SAST Regulations, detail their shareholding in Paras Healthcare. As of October 30, 2026, the acquirers and their persons acting in concert (PACs) hold 78,81,992 shares, representing 7.28% of the total diluted capital. The acquisition mode is described as unlisted shares conversion into listed shares on account of an IPO, with the shares listed on October 28, 2026. The total equity share capital before and after the acquisition was 10,82,01,194 shares, with a total diluted share capital of 10,85,00,790 shares.